References
- YawnBPWollanPCSchroederCGazzuolaLMehtaMTemporal and gender-related trends in brain metastases from lung and breast cancerMinn Med200386323714719614
- HanibuchiMKimSJFidlerIJNishiokaYThe molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectivesJ Med Invest2014613–424125325264041
- TsaoMNRadesDWirthARadiotherapeutic and surgical management for newly diagnosed brain metastases(es): An American Society for Radiation Oncology evidence-based guidelinePract Radiat Oncol2012221022525925626
- KocherMSoffiettiRAbaciogluUAdjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 studyJ Clin Oncol20112913414121041710
- PatchellRATibbsPAWalshJWA randomized trial of surgery in the treatment of single metastases to the brainN Engl J Med1990223224945002405271
- AndrewsDWScottCBSperdutoPWWhole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialLancet20043631665167215158627
- EichlerAFKahleKTWangDLEGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancerNeuro Oncol201012111193119920627894
- Jamal-HanjaniMSpicerJEpidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brainClin Cancer Res201218493894422167408
- WuCLiYLWangZMLiZZhangTXWeiZGefitinib as palliative therapy for lung adenocarcinoma metastatic to the brainLung Cancer200757335936417434236
- D’AntonioCPassaroAGoriBBone and brain metastasis in lung cancer: recent advances in therapeutic strategiesTher Adv Med Oncol20146310111424790650
- SperdutoPWKasedNRobergeDSummary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesJ Clin Oncol201230441942522203767
- ShenKRMeyersBFLarnerJMJonesDRAmerican College of Chest PhysiciansSpecial treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)Chest20071323 Suppl290S305S17873175
- KhuntiaDBrownPLiJMehtaMPWhole-brain radiotherapy in the management of brain metastasisJ Clin Oncol20062481295130416525185
- LangleyREStephensRJNankivellMInterim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?Clin Oncol (R Coll Radiol)2013253e23e3023211715
- ChangELWefelJSHessKRAllenPKNeurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialLancet Oncol200910111037104419801201
- YamamotoMSerizawaTShutoTStereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational studyLancet Oncol201415438739524621620
- FanYXuXXieCEGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published dataOnco Targets Ther201472075208425419145
- MitsudomiTMoritaSYatabeYGefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialLancet Oncol201011212112820022809
- ZhouCWuYLChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
- RosellRCarcerenyEGervaisRErlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomized phase 3 trialLancet Oncol20121323924622285168
- WuYLZhouCHuCPAfatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trialLancet Oncol201415221322224439929
- ZhaoXZhuGChenHYangPLiFDuNEfficacy of icotinib versus traditional chemotherapy as first-line treatment for preventing brain metastasis from advanced lung adenocarcinoma in patients with epidermal growth factor receptor-sensitive mutationJ Cancer Res Ther201410SupplC155C15925450275